News

Under the terms of the agreement, Ligand has received an undisclosed initial payment, and is entitled to receive up to $45 million in potential regulatory and commercial milestone

The acquisition will build on Mylan’s existing partnerships with Famy Care in North America, Europe and Australia, and provide Mylan with an enhanced and now vertically integrated platform

The drug is indicated to treat patients with STS, including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline. STS are a type of cancer

These are in addition to multiple other patents that have been issued and granted in the United States, Mexico and Australia for ophthalmic administration of voclosporin. Further patent

The cell bank contains over 2.6 billion human cells, sufficient to meet the company’s foreseeable clinical trial requirements. "Completing the production of clinical-grade cells using the previously published

Following a meeting with its CBD Initiative Scientific/Medical Advisory Board last November, the company has marked significant progress in readying its first natural CBD-based nutraceutical supplement for introduction

The research collaboration for Moderna will be managed by its venture company Valera, which is focused on the advancement of vaccines and therapeutics for the prevention and treatment

BASIS has been developed to support metabolic and cellular health, improve biological functions such as muscle repair and inflammatory response, and promote healthy aging with memory and cardiovascular

The drug is approved in combination with letrozole, to treat postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced breast cancer as initial endocrine-based